A detailed history of Amalgamated Bank transactions in Glaukos Corp stock. As of the latest transaction made, Amalgamated Bank holds 15,926 shares of GKOS stock, worth $2.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
15,926
Previous 15,247 4.45%
Holding current value
$2.3 Million
Previous $1.8 Million 15.02%
% of portfolio
0.02%
Previous 0.02%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$113.62 - $135.39 $77,147 - $91,929
679 Added 4.45%
15,926 $2.08 Million
Q2 2024

Aug 12, 2024

SELL
$89.48 - $118.35 $8,232 - $10,888
-92 Reduced 0.6%
15,247 $1.8 Million
Q1 2024

Apr 23, 2024

SELL
$76.4 - $96.33 $415,692 - $524,131
-5,441 Reduced 26.18%
15,339 $1.45 Million
Q4 2023

Feb 06, 2024

SELL
$59.53 - $85.11 $48,457 - $69,279
-814 Reduced 3.77%
20,780 $1.65 Million
Q3 2023

Nov 08, 2023

SELL
$69.23 - $79.09 $9,761 - $11,151
-141 Reduced 0.65%
21,594 $1.63 Million
Q2 2023

Aug 11, 2023

BUY
$45.44 - $71.21 $12,859 - $20,152
283 Added 1.32%
21,735 $1.55 Million
Q1 2023

May 02, 2023

SELL
$43.88 - $52.48 $71,129 - $85,070
-1,621 Reduced 7.03%
21,452 $1.08 Million
Q4 2022

Feb 10, 2023

BUY
$40.82 - $57.75 $8,327 - $11,781
204 Added 0.89%
23,073 $1.01 Million
Q3 2022

Nov 09, 2022

BUY
$46.84 - $58.49 $17,611 - $21,992
376 Added 1.67%
22,869 $1.22 Million
Q2 2022

Aug 15, 2022

SELL
$34.86 - $63.77 $13,665 - $24,997
-392 Reduced 1.71%
22,493 $1.02 Million
Q1 2022

Jun 30, 2022

SELL
$44.33 - $57.82 $49,294 - $64,295
-1,112 Reduced 4.63%
22,885 $1.32 Million
Q4 2021

Feb 15, 2022

SELL
$40.27 - $56.99 $3,503 - $4,958
-87 Reduced 0.36%
23,997 $1.07 Million
Q3 2021

Oct 29, 2021

SELL
$47.43 - $84.23 $35,714 - $63,425
-753 Reduced 3.03%
24,084 $1.16 Million
Q2 2021

Aug 16, 2021

BUY
$73.06 - $97.7 $1.34 Million - $1.79 Million
18,365 Added 283.76%
24,837 $2.11 Million
Q1 2021

May 13, 2021

SELL
$70.43 - $97.42 $41,764 - $57,770
-593 Reduced 8.39%
6,472 $543,000
Q4 2020

Feb 12, 2021

BUY
$48.9 - $75.26 $5,134 - $7,902
105 Added 1.51%
7,065 $531,000
Q3 2020

Oct 30, 2020

SELL
$37.23 - $50.97 $5,658 - $7,747
-152 Reduced 2.14%
6,960 $345,000
Q2 2020

Aug 10, 2020

SELL
$28.78 - $46.83 $5,266 - $8,569
-183 Reduced 2.51%
7,112 $273,000
Q1 2020

May 13, 2020

BUY
$25.53 - $70.14 $663 - $1,823
26 Added 0.36%
7,295 $225,000
Q4 2019

Feb 13, 2020

BUY
$54.18 - $65.64 $52,012 - $63,014
960 Added 15.22%
7,269 $396,000
Q3 2019

Nov 13, 2019

SELL
$58.58 - $83.91 $5,213 - $7,467
-89 Reduced 1.39%
6,309 $394,000
Q2 2019

Aug 14, 2019

BUY
$63.59 - $78.71 $82,031 - $101,535
1,290 Added 25.25%
6,398 $482,000
Q1 2019

May 15, 2019

BUY
$50.75 - $80.54 $10,454 - $16,591
206 Added 4.2%
5,108 $400,000
Q4 2018

Feb 15, 2019

BUY
$52.18 - $67.93 $255,786 - $332,992
4,902 New
4,902 $275,000
Q3 2018

Nov 14, 2018

SELL
$38.13 - $68.37 $192,480 - $345,131
-5,048 Closed
0 $0
Q2 2018

Jul 18, 2018

BUY
$27.62 - $44.51 $139,425 - $224,686
5,048 New
5,048 $205,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.86B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.